Heat biologics, inc. (HTBX)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Dec'12
Assets
Current Assets
Cash and cash equivalents

20,738

9,039

9,334

13,828

17,896

22,154

20,962

24,660

8,962

9,763

4,288

8,345

11,129

7,842

8,464

7,115

9,975

4,939

8,210

11,451

10,270

3,714

3,281

5,983

2,690

4,566

23,578

3,015

5

Short-term investments

-

-

5,683

5,648

5,611

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Short-term investments

5,706

5,713

-

-

-

5,570

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Investments, held to maturity (net)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

1,859

6,689

6,742

7,912

10,781

10,699

12,115

10,864

16,749

17,297

-

-

0

Accounts receivable

144

34

37

77

79

28

68

14

5

14

1

10

2

82

131

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Related party receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

43

36

30

-

20

16

9

Prepaid expenses and other current assets

537

420

734

684

818

961

2,477

4,007

1,652

1,967

1,935

273

279

338

528

440

648

869

986

836

1,099

863

648

668

862

1,066

800

500

58

Total Current Assets

27,126

15,209

15,789

20,238

24,406

28,714

23,508

28,682

10,620

11,745

6,225

8,629

11,411

8,263

9,125

7,555

12,483

12,498

15,940

20,200

22,151

15,276

16,088

17,552

20,332

22,930

24,399

3,532

73

Property and Equipment, net

705

559

609

566

621

643

663

645

661

286

320

308

332

359

392

423

444

445

467

494

428

446

464

480

56

53

13

9

10

Other Assets
In-process R&D

5,866

5,866

-

-

-

5,866

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

0

1

1

2

2

2

101

101

101

100

101

101

101

101

101

101

101

1

1

1

1

26

26

In-process R&D

-

-

5,866

5,866

5,866

-

5,866

5,866

5,866

5,866

5,866

5,866

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Goodwill

1,452

1,452

1,452

2,189

2,189

2,189

2,189

2,189

2,189

2,189

2,189

2,189

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease right-of-use asset

2,211

2,287

347

406

463

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Finance lease right-of-use asset

336

187

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deposits

122

394

386

436

351

351

99

79

79

69

69

69

69

69

69

69

69

69

69

69

69

20

19

19

9

9

9

9

9

Related party receivable

-

-

-

-

-

-

-

-

-

-

0

0

103

103

103

85

58

58

58

58

58

49

-

-

-

24

-

-

-

Deferred financing costs

-

-

-

-

-

-

0

0

40

30

46

-

-

0

0

0

0

44

25

28

22

24

62

-

-

0

0

24

28

Total Other Assets

9,989

10,188

8,051

8,897

8,870

8,406

8,154

8,135

8,175

8,157

8,173

8,127

273

273

273

254

228

273

254

257

251

194

183

21

10

35

-

-

63

Total Other Assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10

60

-

Total Assets

37,821

25,956

24,451

29,702

33,897

37,763

32,325

37,464

19,458

20,189

14,719

17,064

12,017

8,896

9,792

8,233

13,157

13,217

16,662

20,952

22,831

15,916

16,736

18,054

20,400

23,020

24,423

3,602

147

Liabilities and Stockholders' Equity
Current Liabilities
Accounts payable

1,350

1,503

1,944

1,979

1,618

974

976

821

1,701

1,033

1,214

1,007

734

290

501

478

1,488

1,980

936

814

819

1,367

680

720

378

651

392

1,319

505

Deferred revenue, current portion

2,508

3,410

-

-

-

1,032

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

340

-

3,090

5,130

6,273

7,026

938

1,409

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contingent consideration, current portion

1,659

1,579

1,477

1,222

1,209

1,187

1,217

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liability, current portion

222

216

91

129

166

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Finance lease liability, current portion

103

49

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses and other liabilities

1,092

1,676

1,281

1,169

948

1,678

1,530

1,445

1,558

2,276

994

702

754

1,305

830

1,080

1,496

1,846

2,074

1,168

724

806

446

320

378

503

157

211

129

Accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

25

22

43

13

Current portion of long term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,040

3,133

3,133

3,133

2,053

1,009

703

397

130

-

-

0

0

150

66

Total Current Liabilities

6,936

8,435

4,794

4,499

4,283

4,872

6,814

7,398

9,534

10,336

3,147

3,119

1,488

1,595

3,372

4,692

6,118

6,961

5,064

2,991

2,247

2,570

1,256

1,040

756

1,180

571

1,724

715

Long Term Liabilities
Long term debt, net of discount and current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

839

2,027

2,808

3,611

2,831

3,998

2,031

2,314

1,058

-

-

0

0

574

658

Convertible notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

197

Other long-term liabilities

14

-

306

293

261

213

188

156

160

160

449

439

421

461

439

396

259

149

12

12

-

0

0

0

0

122

-

-

92

Derivative warrant liability

41

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax liability

361

361

-

-

-

316

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue, net of current portion

200

200

-

-

-

200

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax liability

-

-

361

361

361

-

637

1,302

1,302

1,302

2,111

2,111

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue, net of current portion

-

-

200

200

200

-

200

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liability, net of current portion

1,462

1,519

259

282

304

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Financing lease liability, net of current portion

241

142

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contingent consideration, net of current portion

2,032

2,139

2,356

2,109

2,010

1,918

2,058

3,160

2,620

2,609

2,385

2,385

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock warrants liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

214

193

-

Total Liabilities

11,290

12,798

8,278

7,747

7,421

7,520

9,898

12,017

13,617

14,408

8,094

8,056

1,910

2,056

4,651

7,116

9,186

10,723

7,908

7,002

4,279

4,884

2,315

1,040

756

1,302

786

2,492

1,662

Commitments and Contingencies (Note 9 and 13)

-

-

-

-

-

-

0

0

0

-

-

-

0

0

0

0

-

0

0

0

0

0

-

-

-

0

-

-

-

Stockholders' Equity
Common stock, $.0002 par value; 100,000,000 shares authorized, 77,924,516 and 33,785,999 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

15

6

6

6

6

6

4

4

1

0

6

6

6

0

4

3

3

1

1

1

1

1

0

0

0

0

0

0

0

Additional paid-in capital

137,692

118,173

117,836

117,350

116,943

114,883

104,378

103,953

80,153

76,382

73,871

73,726

72,441

65,872

60,704

54,981

54,851

48,566

48,038

47,779

47,463

35,895

35,550

35,016

34,686

34,337

34,139

9,583

4,495

Accumulated deficit

-110,889

-104,597

-101,261

-95,066

-90,295

-84,580

-79,642

-76,423

-72,373

-68,846

-65,714

-63,413

-60,194

-57,004

-53,532

-51,915

-48,990

-44,430

-37,943

-32,758

-

-24,135

-

-

-

-

-10,287

-8,319

-

Accumulated other comprehensive income (loss)

207

-11

52

-11

-28

-19

-55

-94

-144

-166

-172

-148

-138

-72

-149

-113

-162

-86

-64

-37

-20

0

-

-

-

-

-

-

-

Accumulated deficit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

28,044

-

20,524

17,524

14,677

12,346

-

-

5,935

Total Stockholders' Equity - Heat Biologics, Inc.

27,025

13,571

16,634

22,279

26,626

30,289

24,685

27,440

7,637

7,370

7,991

10,171

12,115

8,796

7,026

2,955

5,701

4,050

10,032

14,985

19,399

11,761

15,026

17,493

20,010

21,991

23,853

1,264

-1,515

Non-Controlling Interest

-495

-413

-460

-324

-150

-46

-2,258

-1,993

-1,796

-1,589

-1,365

-1,162

-2,007

-1,956

-1,885

-1,838

-1,730

-1,555

-1,278

-1,036

-846

-729

-605

-478

-367

-274

-216

-154

76

Total Stockholders' Equity

26,530

13,157

16,173

21,955

26,475

30,242

22,427

25,447

5,840

5,780

6,625

9,008

10,107

6,839

5,141

1,117

3,971

2,494

8,754

13,949

18,552

11,032

14,421

17,014

19,643

21,717

23,636

1,110

-1,438

Total Liabilities and Stockholders' Equity

37,821

25,956

24,451

29,702

33,897

37,763

32,325

37,464

19,458

20,189

14,719

17,064

12,017

8,896

9,792

8,233

13,157

13,217

16,662

20,952

22,831

15,916

16,736

18,054

20,400

23,020

24,423

3,602

147